Federal contract award
36C24526N0555
PATIENT MEDICATION OF OXERCATE .002% FOR DIRECT SHIPMENT TO THE PATIENTS HOME.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 245-NETWORK CONTRACT OFFICE 5 (36C245) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79720D0017 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $166.5K |
| Current contract value | $166.5K |
| Potential contract value / ceiling | $166.5K |
| Start date | Apr 28, 2026 |
| Current end date | Apr 30, 2026 |
| Potential end date | May 29, 2026 |
| Latest award activity | Apr 30, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 30, 2026 | 0 | $166.5K | PATIENT MEDICATION OF OXERCATE .002% FOR DIRECT SHIPMENT TO THE PATIENTS HOME. |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.